IP Library › Assignment 061606/0837
Patent Assignment
Reel/Frame 061606/0837

Change of Name

Recorded: 2022-10-05 Pages: 3
Assignor
CYDEX, INC.
Executed: 2007-11-19
Assignee
CYDEX PHARMACEUTICALS, INC.
10513 W. 84TH TERRACE, LENEXA, KANSAS, 66214
Covered Properties (4)
Inhalant Formulation Containing Sulfoalkyl Ether Cyclodextrin and Corticosteroid
Patent: 9,827,324 →
Application: 13/586,380 →
Publication: US 2013/0059826
Inhalant Formulation Containing Sulfoalkyl Ether Cyclodextrin and Corticosteroid
Application: 13/676,744 →
Publication: US 2013/0303498
Inhalant Formulation Containing Sulfoalkyl Ether Cyclodextrin and Corticosteroid
Application: 15/817,056 →
Publication: US 2018/0154015
Inhalant Formulation Containing Sulfoalkyl Ether Cyclodextrin and Corticosteroid
Application: 16/210,561 →
Publication: US 2019/0105404
Related Assignments (2)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Oct 4, 2022
From: PIPKIN, JAMES D.; ZIMMERER, RUPERT O.; THOMPSON, DIANE O.; MOSHER, GEROLD L.
To: CYDEX, INC.
Reel/Frame 061308/0844 →
Security Interest Oct 18, 2023
From: CYDEX PHARMACEUTICALS, INC.; LIGAND PHARMACEUTICALS INCORPORATED; METABASIS THERAPEUTICS, INC.; PFENEX INC.
To: CITIBANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 065271/0025 →